Robin Shane Readnour

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
19 Dec 24	ANTX AN2 Therapeutics	Common Stock	Grant	Acquire A	No	No	0	9,077	0.00	9,077
10 Dec 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.4935	5,000	7.47 k	652,573
10 Dec 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.4924	5,000	7.46 k	582,288
9 Dec 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.4287	18,483	26.41 k	647,573
9 Dec 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.4303	12,289	17.58 k	577,288
6 Dec 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.4466	6,517	9.43 k	629,090
6 Dec 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.445	12,711	18.37 k	564,999
27 Nov 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.4167	25,000	35.42 k	622,573
27 Nov 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.4169	25,000	35.42 k	552,288
26 Nov 24	ANTX AN2 Therapeutics	Common Stock	Buy	Acquire P	Yes	No	1.3942	12,500	17.43 k	597,573

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.